Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer

Abstract

Use of nonselective beta-blockers in patients with EOC was associated with longer OS. These findings may have implications for new therapeutic approaches. Cancer 2015;121:3435-43. © 2015 American Cancer Society.